Evidence map›Paper›PMID 18765663›Full record

ArticleThe Journal of biological chemistry2008

The sushi domains of secreted GABA(B1) isoforms selectively impair GABA(B) heteroreceptor function.

Jim Y Tiao, Amyaouch Bradaia, Barbara Biermann, Klemens Kaupmann, Michaela Metz, Corinne Haller, Antonius G Rolink, Elin Pless, Paul N Barlow, Martin Gassmann and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Monoallelic de novoScience advances · 2024
    Article
  3. Review
  4. Mechanisms and Regulation of Neuronal GABACurrent topics in behavioral neurosciences · 2022
    Review
  5. Article
  6. Review
  7. Diversity of structure and function of GABAProceedings of the Japan Academy. Series B, Physical and biological sciences · 2018
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Sushi domains confer distinct trafficking profiles on GABAB receptors.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  14. Review
  15. GABAB receptor complex as a potential target for tumor therapy.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2012
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Jim Y TiaoDepartment of Biomedicine, Institute of Physiology, Pharmazentrum, University of Basel, CH-4056 Basel, Switzerland.
Amyaouch Bradaia
Barbara Biermann
Klemens Kaupmann
Michaela Metz
Corinne Haller
Antonius G Rolink
Elin Pless
Paul N Barlow
Martin Gassmann
Bernhard Bettler
University of Basel · CHDepartment of Biomedicine Basel · CHUniversity of Edinburgh · GBNovartis (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GABA(B) receptors are the G-protein-coupled receptors for gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter in the brain. GABA(B) receptors are promising drug targets for a wide spectrum of psychiatric and neurological disorders. Receptor subtypes exhibit no pharmacological differences and are based on the subunit isoforms GABA(B1a) and GABA(B1b). GABA(B1a) differs from GABA(B1b) in its ectodomain by the presence of a pair of conserved protein binding motifs, the sushi domains (SDs). Previous work showed that selectively GABA(B1a) contributes to heteroreceptors at glutamatergic terminals, whereas both GABA(B1a) and GABA(B1b) contribute to autoreceptors at GABAergic terminals or to postsynaptic receptors. Here, we describe GABA(B1j), a secreted GABA(B1) isoform comprising the two SDs. We show that the two SDs, when expressed as a soluble protein, bind to neuronal membranes with low nanomolar affinity. Soluble SD protein, when added at nanomolar concentrations to dissociated hippocampal neurons or to acute hippocampal slices, impairs the inhibitory effect of GABA(B) heteroreceptors on evoked and spontaneous glutamate release. In contrast, soluble SD protein neither impairs the activity of GABA(B) autoreceptors nor impairs the activity of postsynaptic GABA(B) receptors. We propose that soluble SD protein scavenges an extracellular binding partner that retains GABA(B1a)-containing heteroreceptors in proximity of the presynaptic release machinery. Soluble GABA(B1) isoforms like GABA(B1j) may therefore act as dominant-negative inhibitors of heteroreceptors and control the level of GABA(B)-mediated inhibition at glutamatergic terminals. Of importance for drug discovery, our data also demonstrate that it is possible to selectively impair GABA(B) heteroreceptors by targeting their SDs.

Indexed as

Amino Acid MotifsAnimalsBase Sequencegamma-Aminobutyric AcidGene Expression RegulationHippocampusHumansMiceMolecular Sequence DataPresynaptic TerminalsProtein IsoformsProtein Structure, TertiaryRatsReceptors, GABA-BSynaptic Membranesgamma-Aminobutyric AcidProtein IsoformsReceptors, GABA-B

Identifiers

PMID18765663
PMCPMC2576543
OpenAlexW2057628223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.